10/24
07:08 am
xrtx
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 [Financial Post (Toronto, Ontario, Canada)]
Low
Report
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 [Financial Post (Toronto, Ontario, Canada)]
10/24
07:00 am
xrtx
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
Low
Report
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
10/18
04:00 pm
xrtx
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
Medium
Report
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
10/17
08:11 am
xrtx
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement [Financial Post (Toronto, Ontario, Canada)]
High
Report
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement [Financial Post (Toronto, Ontario, Canada)]
10/17
08:00 am
xrtx
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
High
Report
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
10/9
05:08 am
xrtx
XORTX Initiates Precision Medicine Program [Yahoo! Finance]
Medium
Report
XORTX Initiates Precision Medicine Program [Yahoo! Finance]
10/9
05:00 am
xrtx
XORTX Initiates Precision Medicine Program
Medium
Report
XORTX Initiates Precision Medicine Program
9/13
07:05 am
xrtx
XORTX Announces Results of Annual and Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
XORTX Announces Results of Annual and Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
9/13
07:00 am
xrtx
XORTX Announces Results of Annual and Special Meeting of Shareholders
Medium
Report
XORTX Announces Results of Annual and Special Meeting of Shareholders
9/12
05:32 pm
xrtx
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A [Financial Post (Toronto, Ontario, Canada)]
Low
Report
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A [Financial Post (Toronto, Ontario, Canada)]
9/12
05:30 pm
xrtx
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
Neutral
Report
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
9/6
05:37 pm
xrtx
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders [Yahoo! Finance]
Low
Report
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders [Yahoo! Finance]
9/6
05:36 pm
xrtx
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
Low
Report
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
9/6
05:30 pm
xrtx
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
Low
Report
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
9/3
12:37 pm
xrtx
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
9/3
12:30 pm
xrtx
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
Medium
Report
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
8/29
07:12 am
xrtx
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism [Financial Post (Toronto, Ontario, Canada)]
High
Report
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism [Financial Post (Toronto, Ontario, Canada)]
8/29
07:00 am
xrtx
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
High
Report
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism